Survey of Ophthalmology
Volume 51, Issue 2 , Pages 137-152 , March 2006

The Role of Inflammation in the Pathogenesis of Age-related Macular Degeneration

  • Larry A. Donoso, MD, PhD

      Affiliations

    • The Henry and Corinne Bower Laboratory, the Eye Research Institute, Wills Eye Hospital, Philadelphia, Pennsylvania
    • International Retinal Research Foundation, Birmingham, Alabama
    • Corresponding Author InformationReprint address: Larry A. Donoso, MD, PhD, Bower Research Laboratory, P.O. Box 53429, Philadelphia, PA 19105.
    • ,
  • David Kim

      Affiliations

    • The Henry and Corinne Bower Laboratory, the Eye Research Institute, Wills Eye Hospital, Philadelphia, Pennsylvania
    • ,
  • Arcilee Frost

      Affiliations

    • The Henry and Corinne Bower Laboratory, the Eye Research Institute, Wills Eye Hospital, Philadelphia, Pennsylvania
    • ,
  • Alston Callahan, MD

      Affiliations

    • International Retinal Research Foundation, Birmingham, Alabama
    • ,
  • Gregory Hageman, PhD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, Iowa, USA

References 

  1. ___: Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107:2224–32, 2000
  2. ___: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons disease chromosomes. The Huntingtons Disease Collaborative Research Group. Cell 72:971–83, 1993
  3. ___: Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 110:1701–8, 1992
  4. Abecasis GR, Yashar BM, Zhao Y, et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet. 2004;74:482–494
  5. Allikmets R. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;17:122
  6. Ambati J, Ambati BK, Yoo SH, et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257–293
  7. Anderson DH, Mullins RF, Hageman GS, et al. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411–431
  8. Anderson DH, Talaga KC, Rivest AJ, et al. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res. 2004;78:243–256
  9. Anderson JL. Infection, antibiotics, and atherothrombosis—end of the road or new beginnings?. N Engl J Med. 2005;352:1706–1709
  10. Ashwell G, Morell A. The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins. Biochem Soc Symp. 1974;40:117–124
  11. Blackmore TK, Fischetti VA, Sadlon TA, et al. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun. 1998;66:1427–1431
  12. Blumenkranz MS, Russell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;93:552–558
  13. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33(Suppl):228–237
  14. Botto M: Links between complement deficiency and apopthsis. Arthritis Res 3:207–10, 200
  15. Chaine G, Hullo A, Sahel J, et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol. 1998;82:996–1002
  16. Cho E, Hankinson SE, Willett WC, et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol. 2000;118:681–688
  17. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112:533–539
  18. Colville D, Guymer R, Sinclair RA, et al. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II (dense deposit disease). Am J Kidney Dis. 2003;42:E2–E5
  19. Congdon N, OColmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485
  20. Cousins SW, Espinosa-Heidmann DG, Csaky KG. Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?. Arch Ophthalmol. 2004;122:1013–1018
  21. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682–14687
  22. Daiger SP. Identifying retinal disease genes: how far have we come, how far do we have to go?. Novartis Found Symp. 2004;255:17–27discussion 27–36
  23. Dasch B, Fuhs A, Behrens T, et al. Inflammatory markers in age related maculopathy. Cross section anayysis from the Muenster Aging and Retina Study. Arch Ophthalmol. 2005;123:1501–1506
  24. Davies JC, Griesenbach U, Alton E. Modifier genes in cystic fibrosis. Pediatr Pulmonol. 2005;39:383–391
  25. DeAngelis MM, Lane AM, Shah CP, et al. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 2004;122:575–580
  26. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med. 2000;343:37–49
  27. Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med. 2000;343:108–117
  28. Donoso LA, Edwards AO, Frost A, et al. Autosomal dominant Stargardt-like macular dystrophy. Surv Ophthalmol. 2001;46:149–163
  29. Donoso LA, Edwards AO, Frost AT, et al. Clinical variability of Stickler syndrome: role of exon 2 of the collagen COL2A1 gene. Surv Ophthalmol. 2003;48:191–203
  30. Donoso LA, Hageman G, Frost A, et al. Autosomal dominant macular dystrophy in a large Canadian family. Can J Ophthalmol. 2003;38:33–40
  31. Dryja TP. Gene-based approach to human gene-phenotype correlations. Proc Natl Acad Sci USA. 1997;94:12117–12121
  32. Dryja TP, Hahn LB, Kajiwara K, et al. Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1997;38:1972–1982
  33. Dryja TP, McGee TL, Hahn LB, et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 1990;323:1302–1307
  34. Duthy TG, Ormsby RJ, Giannakis E, et al. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect Immun. 2002;70:5604–5611
  35. Edwards AO, Ritter Iii R, Abel KJ, et al: Complement Factor H. Spolymorphism and age-related macular degenerationcience 10:10, 2005
  36. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227–253
  37. Ewing B, Green P. Analysis of expressed sequence tags indicates 35,000 human genes. Nat Genet. 2000;25:232–234
  38. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640–1642
  39. Fine SL. Age-related macular degeneration 1969-2004: a 35-year personal perspective. Am J Ophthalmol. 2005;139:405–420
  40. Fishelson A, Attali G, Mevorach D. Complement and apoptosis. Mol Immunol. 2001;38:207–219
  41. Forrester JV, McMenamin PG. Immunopathogenic mechanisms in intraocular inflammation. Chem Immunol. 1999;73:159–185
  42. Framme C, Herboth T, Roider J, et al. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II]. Klin Monatsbl Augenheilkd. 1998;213:252–253
  43. Friedman DS, OColmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572
  44. Fung YK, Murphree AL, TAng A, et al. Structural evidence for the authenticity of the human retinoblastoma gene. Science. 1987;236:1657–1661
  45. Garrod AE. The Incidence of Alkaptonuria: A study in chemical individuality. Lancet. 1902;2:1616–1620
  46. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol. 1967;63(Suppl):1–139
  47. Giannakis E, Jokiranta TS, Male DA, et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol. 2003;33:962–969
  48. Giannakis E, Jokiranta TS, Ormsby RJ, et al. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol. 2002;168:4585–4592
  49. Giannakis E, Male DA, Ormsby RJ, et al. Multiple ligand binding sites on domain seven of human complement factor H. Int Immunopharmacol. 2001;1:433–443
  50. Goldberg AF, Molday RS. Defective subunit assembly underlies a digenic form of retinitis pigmentosa linked to mutations in peripherin/rds and rom-1. Proc Natl Acad Sci USA. 1996;93:13726–13730
  51. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv. 1990;9:529–554
  52. Gordon DL, Kaufman RM, Blackmore TK, et al. Identification of complement regulatory domains in human factor H. J Immunol. 1995;155:348–356
  53. Goverdhan SV, Howell MW, Mullins RF, et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2005;46:1726–1734
  54. Guymer RH, Chiu AW, Lim L, et al. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?. Surv Ophthalmol. 2005;50:194–206
  55. Haab O. Erkankungen der Macula Lutea. Centralblat Augenheilkd. 1885;9:384–391
  56. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227–7232
  57. Hageman GS, Luthert PJ, Victor Chong NH, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruchs membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–732
  58. Hageman GS, Mullins RF, Russell SR, et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J. 1999;13:477–484
  59. Haines JL, Hauser MA, Schmidt S, et al. Complement Factor H variant increases the risk of age-related macular degeneration. Science. 2005;10:419–421
  60. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
  61. Hayashi M, Merriam JE, Klaver CC, et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet. 2004;25:111–119
  62. Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127:565–573
  63. Heiba IM, Elston RC, Klein BE, et al. Sibling correlations and segregation analysis of age-related maculopaty: The Beaver Dam Eye Study. Genet Epidemiol. 1994;11:51–67
  64. Helisalmi S, Hiltunen M, Vepsäläinen S, et al. Polymorphisms in neprilysin gene affect the risk of Alzheimers disease in Finnish patients. J Neurol Neurosurg Psychiatry. 2004;75:1746–1748
  65. Huang SJ, Costa DL, Gross NE, et al. Peripheral drusen in membranoproliferative glomerulonephritis type II. Retina. 2003;23:429–431
  66. Hutchinson JT. Symmetrical central chorioretinal disease occurring in senile persons. R London Ophthalmol Hosp Rep. 1875;8:231–244
  67. Hyman L, Schachat AP, He Q, et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol. 2000;118:351–358
  68. Jakobsdottir J, Conley YP, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005;77:389–407
  69. Johnson LV, Leitner WP, Rivest AJ, et al. The Alzheimers A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:11830–11835
  70. Johnson LV, Leitner WP, Staples MK, et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res. 2001;73:887–896
  71. Johnson LV, Ozaki S, Staples MK, et al. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000;70:441–449
  72. Jozsi M, Manuelian T, Heinen S, et al. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology. Histol Histopathol. 2004;19:251–258
  73. Kajiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science. 1994;264:1604–1608
  74. Kelm S, Schauer R, Crocker PR. The Sialoadhesins—a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily. Glycoconj J. 1996;13:913–926
  75. Kenealy SJ, Schmidt S, Agarwal A, et al. Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol Vis. 2004;10:57–61
  76. Khoubian FJ, Shakin EP, Tanti A, et al. Autosomal dominant pattern dystrophy: Identification of a novel splice site mutation in the peripherin/RDS gene. Retina. 2005;25:999–1004
  77. Kini MM, Leibowitz JM, Colton T, et al. Prevalence of senile cataract, diabetic retinopathy, senile macular degneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol. 1978;85:28–34
  78. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63:200–206
  79. Klaver CC, Wolfs RC, Assink JJ, et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol. 1998;116:1646–1651
  80. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol. 1994;112:932–937
  81. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116:1082–1088
  82. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 1999;117:1203–1210
  83. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology. 2003;110:25–33
  84. Klein R, Klein BE, Tomany SC, et al. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol. 2003;121:674–678
  85. Klein RJ, Zeiss C, Chew EY, et al. Complement Factor H polymorphism in age-related macular degeneration. Science. 2005;10:385–389
  86. Kornzweig AL. The eye in old age V. Diseases of the macula: a clinicopathologic study. Am J Ophthalmol. 1965;60:835–843
  87. Kotarsky H, Hellwage J, Johnsson E, et al. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol. 1998;160:3349–3354
  88. Lai E. Application of SNP technologies in medicine: lessons learned and future challenges. Genome Res. 2001;11:927–929
  89. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921
  90. Lee WH, Bookstein R, Hong F, et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987;235:1394–1399
  91. Lerner MP, Donoso LA, Nordquist RE, et al. Immunological mimicry between retinal S-antigen and group A streptococcal M proteins. Autoimmunity. 1995;22:95–106
  92. Levinson W, Jawetz E. Medical Mircrobiology and Immunology. New York: McGraw Hill Companies; 2002;ed 7
  93. MacDonald IM, Sasi R. Molecular genetics of inherited eye disorders. Clin Invest Med. 1994;17:474–498
  94. MacDonald IM, Tran M, Musarella MA. Ocular genetics: current understanding. Surv Ophthalmol. 2004;49:159–196
  95. Majewski J, Schultz DW, Weleber RG, et al. Age-related macular degeneration—a genome scan in extended families. Am J Hum Genet. 2003;73:540–550
  96. Marmorstein L. Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review. Ophthalmic Genet. 2004;25:219–226
  97. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci. 2004;1035:104–116
  98. McGwin G, Hall TA, Xie A, Owsley C. The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br J Ophthalmol. 2005;89:1166–1170
  99. Mendel G. Versuche tiber Pflanzen-Hybriden. Verhandlungen des naturforschendend Vereines in Brunn. 1866;4:3–47
  100. Meyers SM, Greene T, Gutman FA. A twin study of age-related macular degeneration. Am J Ophthalmol. 1995;120:757–766
  101. Michaelides M, Hunt DM, Moore AT. The genetics of inherited macular dystrophies. J Med Genet. 2003;40:641–650
  102. Miller DM, Espinosa-Heidmann DG, Legra J, et al. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol. 2004;138:323–328
  103. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology. 1999;42:23–30
  104. Mold C, Kingzette M, Gewurz H. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. J Immunol. 1984;133:882–885
  105. Morell AG, Gregoriadis G, Scheinberg IH, et al. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem. 1971;246:1461–1467
  106. Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15:390–395
  107. Mullins RF, Russell SR, Anderson DH, et al. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835–846
  108. Nathans J, Davenport CM, Maumenee IH, et al. Molecular genetics of human blue cone monochromacy. Science. 1989;245:831–838
  109. Nathans J, Maumenee IH, Zrenner E, et al. Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet. 1993;53:987–1000
  110. Nettleship E. Central areolar choroidal atrophy. Trans Ophthalmol Soc UK. 1884;4:165–166
  111. Nichols BE, Drack AV, Vandenburgh K, et al. A 2 base pair deletion in the RDS gene associated with butterfly-shaped pigment dystrophy of the fovea. Hum Mol Genet. 1993;2:6013
  112. Nichols BE, Sheffield VC, Vandenburgh K, et al. Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet. 1993;3:202–207
  113. Niculescu F, Rus H. The role of complement activation in atherosclerosis. Immunol Res. 2004;30:73–80
  114. Pager CK, Sarin LK, Federman JL, et al. Malattia leventinese presenting with subretinal neovascular membrane and hemorrhage. Am J Ophthalmol. 2001;131:517–518
  115. Penfold PL, Madigan MC, Gillies MC, et al. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385–414
  116. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19:241–247
  117. Piguet B, Wells JA, Palmvang IB, et al. Age-related Bruchs membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol. 1993;77:400–403
  118. Ramanathan Y, Zhang H, Aris V, et al. Functional cloning, sorting, and expression profiling of nucleic acid-binding proteins. Genome Res. 2002;12:1175–1184
  119. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894–3900
  120. Ripoche J, Day AJ, Harris TJ, et al. The complete amino acid sequence of human complement factor H. Biochem J. 1988;249:593–602
  121. Ripoche J, Erdei A, Gilbert D, et al. Two populations of complement factor H differ in their ability to bind to cell surfaces. Biochem J. 1988;253:475–480
  122. Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol. 2004;41:355–367
  123. Royer-Pokora B, Kunkel LM, Monaco AP, et al. Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location. Cold Spring Harb Symp Quant Biol. 1986;51(Pt 1):177–183
  124. Russell SR, Mullins RF, Schneider BL, et al. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol. 2000;129:205–214
  125. Sauer CG, Gehrig A, Warneke-Wittstock R, et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet. 1997;17:164–170
  126. Schick JH, Iyengar SK, Klein BE, et al. A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet. 2003;72:1412–1424
  127. Schmidt S, Klaver C, Saunders A, et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 2002;23:209–223
  128. Schultz DW, Klein ML, Humpert A, et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol. 2003;121:679–683
  129. Schultz DW, Klein ML, Humpert AJ, et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet. 2003;12:3315–3323
  130. Seddon JM, Cote J, Page WF, et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005;123:321–327
  131. Seddon JM, Gensler G, Milton RC, et al. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291:704–710
  132. Seddon JM, Santangelo SL, Book K, et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet. 2003;73:780–790
  133. Silvestri G. Age-related macular degeneration: genetics and implications for detection and treatment. Mol Med Today. 1997;3:84–91
  134. Simonelli F, Margaglione M, Testa F, et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res. 2001;33:325–328
  135. Singh K, Bønaa KH, Jacobsen BK, et al. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromsø Study. Am J Epidemiol. 2001;154:236–244
  136. Small KW, Weber JL, Roses A, et al. North Carolina macular dystrophy is assigned to chromosome 6. Genomics. 1992;13:681–685
  137. Smiddy WE, Fine SL. Prognosis of patients with bilateral macular drusen. Ophthalmology. 1984;91:271–277
  138. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697–704
  139. Smith W, Mitchell P, Leder SR. Dietary fat an fish intake and age-related maculopathy. Arch Ophthalmol. 2000;118:401–404
  140. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol. 1998;125:353–359
  141. Stone EM, Braun TA, Russell SR, et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med. 2004;351:346–353
  142. Stone EM, Lotery AJ, Munier FL, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22:199–202
  143. Tantri A, Vrabec TR, Cu-Unjieng A, et al. X-linked retinoschisis: a clinical and molecular genetic review. Surv Ophthalmol. 2004;49:214–230
  144. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111:1280–1287
  145. Traboulsi EI. The challenges and surprises of studying the genetics of age-related macular degeneration. Am J Ophthalmol. 2005;139:908–911
  146. Tuo J, Bojanowski CM, Chan CC. Genetic factors of age-related macular degeneration. Prog Retin Eye Res. 2004;23:229–249
  147. van Leeuwen R, Klaver CC, Vingerling JR, et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003;121:519–526
  148. Van Lenten L, Ashwell G. Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins. J Biol Chem. 1971;246:1889–1894
  149. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol. 1995;142:404–409
  150. Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058–1066
  151. Walport MJ. Complement. Second of two parts. N Engl J Med. 2001;344:1140–1144
  152. Wang JJ, Foran S, Smith W, et al. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003;121:658–663
  153. Weber BH, Vogt G, Pruett RC, et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsbys fundus dystrophy. Nat Genet. 1994;8:352–356
  154. Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet. 2004;75:174–189
  155. Weleber RG, Carr RE, Murphey WH, et al. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993;111:1531–1542
  156. Wells J, Wroblewski J, Keen J, et al. Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet. 1993;3:213–218
  157. Wildner G, Diedrichs-Möhring M. Autoimmune uveitis and antigenic mimicry of environmental antigens. Autoimmun Rev. 2004;3:383–387
  158. Zack DJD, Molday RS, Nathans J, et al. What can we learn about age-related macular degeneration from other retinal diseases. Molecular Vision. 1999;5:30–45
  159. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598–614
  160. Zhang K, Kniazeva M, Han M, et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet. 2001;27:89–93
  161. Zimmerman LE, McLean IW. Metastatic disease from untreated uveal melanomas. Am J Ophthalmol. 1979;88:524–534
  162. Zipfel PF. Complement factor H: physiology and pathophysiology. Semin Thromb Hemost. 2001;27:191–199
  163. Zipfel PF, Hellwage J, Friese MA, et al. Factor H and disease: a complement regulator affects vital body functions. Mol Immunol. 1999;36:241–248
  164. Zipfel PF, Skerka C, Hellwage J, et al. Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans. 2002;30:971–978

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. This manuscript is dedicated to Alston Callahan, MD, (1911–2005) and to Charles D. Kelman, MD, (1930–2004) two of the co-founders of the International Retinal Research Foundation. Dr. Callahan contributed directly to this manuscript and his help is greatly appreciated. The manuscript was supported, in part, by the Henry and Corinne Bower Laboratory, the Eye Research Institute, and the Elizabeth C. King Trust. The support of L. Stanley Mauger is greatly appreciated. Sandra Blackwood and Thomas Perski provided helpful discussions.

PII: S0039-6257(05)00206-7

doi: 10.1016/j.survophthal.2005.12.001

Survey of Ophthalmology
Volume 51, Issue 2 , Pages 137-152 , March 2006

Article Tools

* Image Usage & Resolution